Structural Mechanism of TRPC3 Channel Activation by the Moonwalker Mutation

This study elucidates the structural mechanism of TRPC3 channel activation by revealing how the moonwalker (T561A) mutation disrupts a polar interaction to induce a pi-bulge-mediated S6 helix rotation and pore dilation, while also demonstrating how DAG stabilizes this open state and the inhibitor BTDM reverses the process.

The Gist

Imagine your body is a bustling city, and your cells are the buildings. To keep the city running, these buildings need to let specific people (ions like calcium and sodium) in and out through special doors. TRPC3 is one of those doors. It's a tiny, four-part gate that usually stays shut until a specific chemical key, called DAG, turns the lock.

For a long time, scientists knew what the door looked like when it was locked (closed) and what it looked like when the key was inserted but the door hadn't swung open yet (a "pre-open" state). But they were missing the most important picture: what the door actually looks like when it is wide open.

This paper is like a high-definition security camera that finally caught the door in the act of swinging open. Here is how they did it and what they found, explained simply:

1. The "Moonwalker" Key

The scientists needed a way to force the door open to take a picture. They used a famous mutation called T561A, which researchers nicknamed the "Moonwalker" mutation.

• The Analogy: Imagine a door that is supposed to stay closed unless you push a button. The "Moonwalker" mutation is like jamming the door open with a stick. The door stays open all the time, even without the button being pushed.
• The Result: Because the door was stuck open, the scientists could take a crystal-clear 3D photo (using a powerful microscope called Cryo-EM) of the channel in its fully open state.

2. The Secret Mechanism: The "π-Bulge"

So, how does the door actually open? The scientists found a clever mechanical trick involving the door's hinges (specifically a part of the protein called the S6 helix).

• The Old State (Closed): In the closed door, the hinge is a straight, rigid rod (an alpha-helix). It's held tight by a "magnetic clasp" (a polar interaction) between two specific parts of the protein.
• The Moonwalker Effect: The mutation breaks that magnetic clasp.
• The New State (Open): Once the clasp breaks, the hinge doesn't just bend; it undergoes a shape-shifting trick called a "π-bulge."
  • The Analogy: Think of a straight garden hose. If you suddenly twist it in the middle to create a little loop or a "bulge," the rest of the hose has to shift. This twist causes the bottom half of the door to rotate and tilt outward, like a revolving door swinging wide open. This creates a wide enough gap for the ions to rush through.

3. The Role of the Key (DAG)

You might wonder, "If the Moonwalker mutation forces the door open, why do we need the natural key (DAG)?"

• The Analogy: Imagine the Moonwalker mutation is like a child holding the door open with their foot. It works, but it's unstable. If the child gets tired, the door might slam shut.
• The Discovery: The natural key, DAG, acts like a doorstop. When DAG binds to the door, it stabilizes the "bulge" and the open position. It holds the door wide open so the ions can flow freely. Without DAG, the door might wobble or close, even if the Moonwalker mutation is present.

4. The "Brake" (BTDM)

The paper also looked at a drug called BTDM, which acts as a brake to stop the channel from opening (useful for treating diseases where the door is stuck open).

• The Analogy: If the door is swinging wide open, BTDM is like a heavy weight dropped on the door handle. It pushes the door parts back toward the center, closing the gap.
• The Twist: Interestingly, even when the brake is applied and the door is closed, the "π-bulge" (the twisted shape) stays there. The door is closed not because the hinge straightened out, but because the whole door was pushed back into the center. This is a unique way of closing the door that scientists hadn't seen before.

Why Does This Matter?

TRPC3 is crucial for the brain (specifically for balance and movement). When this door malfunctions, it can cause diseases like cerebellar ataxia, where people walk with a strange, stumbling gait (hence the "Moonwalker" name).

By understanding exactly how the door opens, rotates, and closes, scientists can now design better medicines. They can create drugs that:

1. Stop the door from opening if it's stuck open (causing disease).
2. Help the door open if it's stuck shut (causing weakness).

In a nutshell: This paper solved the mystery of the TRPC3 channel by catching it in the act of opening. They discovered that the door opens by twisting its hinge into a special loop (the π-bulge) and that a natural chemical key (DAG) acts as a doorstop to keep it open, while a drug (BTDM) acts as a heavy weight to push it shut.

Technical Summary

1. Problem Statement

Transient Receptor Potential Canonical 3 (TRPC3) is a calcium-permeable, non-selective cation channel activated by diacylglycerol (DAG). It plays critical roles in neuronal development, synaptic transmission, and cardiovascular regulation. Despite recent structural advances, a fundamental gap remained: all previously determined TRPC3 structures (including those with agonists bound) captured the channel in a closed, non-conducting state. Consequently, the precise structural rearrangements required for the channel to transition from a resting state to an open, conducting state were unknown.

2. Methodology

The authors employed a multi-faceted approach combining cryo-electron microscopy (cryo-EM), electrophysiology, and mutagenesis to capture distinct functional states of human TRPC3 (hTRPC3):

• Resting State (Apo): To obtain an agonist-free structure, the authors engineered a triple mutant (hTRPC3-3M: E603A, V637A, K607A) targeting the DAG-binding pocket (L2 site). This mutant lost DAG sensitivity but retained responsiveness to synthetic activators. The protein was purified using 4F-peptide solubilization and reconstituted into nanodiscs to preserve native lipids.
• Open State: To capture the open conformation, the authors utilized the constitutively active "moonwalker" mutant (T561A). To manage cytotoxicity during expression, cells were cultured with the high-affinity inhibitor BTDM, which was washed away prior to purification. The purified mutant was also reconstituted into nanodiscs.
• Inhibition State: The study compared the T561A mutant structures with a previously determined BTDM-bound hTRPC6 structure (highly homologous to hTRPC3) to model the inhibition mechanism.
• Techniques:
  • Cryo-EM: Single-particle analysis was performed on hTRPC3-3M (2.8 Å) and hTRPC3-T561A (yielding two states: C4 symmetry at 2.93 Å and C2 symmetry at 3.16 Å).
  • Electrophysiology: Whole-cell patch-clamp recordings were used to validate the functional status of mutants (constitutive activity, agonist sensitivity, and inhibitor response).
  • Structural Analysis: Pore radius calculations (HOLE2), hydrogen bond analysis, and conformational comparisons were performed to map gating trajectories.

3. Key Contributions

• First Agonist-Free Resting State: Determined the high-resolution structure of hTRPC3 in the absence of agonists, confirming that previous agonist-bound structures represented a "pre-open" state rather than a desensitized or resting state.
• First Open State Structure: Solved the first structure of hTRPC3 in a conducting, open conformation using the T561A mutant.
• Mechanistic Insight: Elucidated the specific molecular mechanism of channel opening, identifying a critical $\alpha$-to-$\pi$ helical transition in the S6 transmembrane helix.
• Inhibition Mechanism: Clarified how the inhibitor BTDM closes the pore while preserving specific structural features (the $\pi$-bulge), distinguishing it from the gating mechanism of the moonwalker mutation.

4. Key Results

A. Structural States Identified

1. Resting State (hTRPC3-3M): The L2 DAG-binding site was occupied by an unknown lipid rather than DAG. The channel was in a closed, non-conductive state with a narrow pore constriction.
2. Open State (hTRPC3-T561A-C4): This structure exhibited a C4 symmetric conformation with a significantly dilated pore. The narrowest constriction radius increased from 0.8 Å (pre-open) to 1.5 Å, sufficient for partially hydrated calcium ion permeation. The pore lining residues shifted from hydrophobic (I655) to hydrophilic (N659).
3. Distorted Closed State (hTRPC3-T561A-C2): This C2 symmetric structure showed that DAG binding at only two of the four subunit interfaces (A-D and B-C) caused misalignment of the other interfaces, distorting the selectivity filter and closing the pore. This suggests DAG binding is required to stabilize the symmetric open state.

B. The Activation Mechanism (Moonwalker Mutation)

• Disruption of Polar Interaction: In the pre-open state, a polar interaction exists between N652 (on S6) and T561 (on S5). The T561A mutation disrupts this interaction.
• $\alpha$-to-$\pi$ Transition: The disruption triggers a conformational change in the S6 helix, specifically the formation of a $\pi$-bulge near the middle of the helix.
• S6 Rotation and Tilting: The $\pi$-bulge causes the lower half of the S6 helix to rotate and tilt outward. This movement reconfigures the pore-lining residues and pushes the adjacent S5 helix, resulting in pore dilation.
• Validation: A T561V mutant (which also disrupts the polar interaction but cannot form the specific hydrogen bond) also exhibited constitutive activity, confirming that the loss of the N652-T561 interaction is the primary driver of activation.

C. Mechanism of Inhibition (BTDM)

• BTDM binds to the Inhibitor Binding Pocket-C (IBP-C) between the pore and the voltage-sensor-like domain (VSLD).
• Unlike the moonwalker mutation, BTDM inhibition preserves the $\pi$-bulge in S6.
• Instead, BTDM pushes the S5 helix (specifically residue L558) toward the pore center, forcing the S6 helix to move inward and constrict the pore at the N659 gate. This indicates that the channel can be closed via different structural pathways (disruption of the $\pi$-bulge vs. mechanical pushing of S5/S6).

D. Role of DAG

• DAG binding at the L2 site stabilizes the subunit interfaces. In the T561A-C2 structure, the loss of DAG at two interfaces led to a non-conductive, distorted pore.
• Combining the 3M mutations (disrupting DAG binding) with the T561A mutation significantly reduced constitutive currents, proving that DAG acts as a stabilizer of the open conformation, rather than the sole trigger of the initial opening.

5. Significance

This study resolves a long-standing mystery in TRP channel biology by providing the first structural view of TRPC3 in an open state. The findings reveal that:

1. Gating Mechanism: The opening of TRPC3 is driven by an $\alpha$-to-$\pi$ transition in the S6 helix, a mechanism potentially conserved across the TRP channel family.
2. Allosteric Regulation: The "moonwalker" mutation activates the channel by breaking a specific polar lock (N652-T561), while DAG binding serves to stabilize the resulting open conformation by maintaining subunit symmetry.
3. Therapeutic Implications: Understanding the distinct structural pathways for activation (T561A) and inhibition (BTDM) provides a blueprint for designing specific modulators for TRPC3-related diseases, such as cerebellar ataxia, cardiac hypertrophy, and cancer. The study suggests that targeting the S6 $\pi$-bulge or the S5-S6 interface could offer new avenues for drug development.